2022
Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers
Walsh KM, Zhang C, Calvocoressi L, Hansen HM, Berchuck A, Schildkraut JM, Bondy ML, Wrensch M, Wiemels JL, Claus EB. Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers. Neuro-Oncology Advances 2022, 4: vdac044. PMID: 35702670, PMCID: PMC9187056, DOI: 10.1093/noajnl/vdac044.Peer-Reviewed Original ResearchRisk of meningiomaOvarian cancerBreast cancerER- breast cancerEstrogen receptor statusBody mass indexFemale breast cancerRisk of tumorsReceptor statusMass indexEstrogenic mechanismsHormonal factorsGenome-wide association studiesMeningiomasNormal meningesCancerMinor alleleCase-control datasetUK BiobankExpression quantitative trait lociMeningesRiskTumorsBreastAdiposity traits
2019
MNGI-12. PLEIOTROPIC MLLT10 VARIATION CONFERS RISK OF MENINGIOMA, BREAST, AND OVARIAN CANCERS
Walsh K, Zhang C, Calvocoressi L, Hansen H, Berchuck A, Schildkraut J, Bondy M, Wiemels J, Claus E. MNGI-12. PLEIOTROPIC MLLT10 VARIATION CONFERS RISK OF MENINGIOMA, BREAST, AND OVARIAN CANCERS. Neuro-Oncology 2019, 21: vi142-vi142. PMCID: PMC6847155, DOI: 10.1093/neuonc/noz175.594.Peer-Reviewed Original ResearchBody mass indexER- breast cancerRisk of meningiomaOvarian cancerBreast cancerMeningioma riskCancer riskElevated body mass indexHigher body fat percentageRisk allelesExogenous hormone useEstrogen receptor statusFemale breast cancerBreast cancer riskOvarian cancer riskBody fat percentageEndogenous hormonal factorsRecent genome-wide association studiesReceptor statusWaist circumferenceHormone useMass indexEpidemiologic studiesEstrogenic mechanismsHigh risk
2012
Postmenopausal hormone therapy and ductal carcinoma in situ: A population-based case–control study
Calvocoressi L, Stowe MH, Carter D, Claus EB. Postmenopausal hormone therapy and ductal carcinoma in situ: A population-based case–control study. Cancer Epidemiology 2012, 36: 161-168. PMID: 22317899, PMCID: PMC3613248, DOI: 10.1016/j.canep.2012.01.001.Peer-Reviewed Original ResearchConceptsPopulation-based case-control studyCase-control studyHormone therapySitu breast cancerBreast cancerDuctal carcinomaRisk of DCISPostmenopausal hormone therapyFrequency-matched controlsInvasive breast cancerPost-menopausal womenDuration of usePostmenopausal womenIncident casesBreast carcinomaDCISLarger studyCarcinomaCancerImportant covariatesEstrogenTherapyAge intervalsWomenCurrent use
2011
Family and personal medical history and risk of meningioma.
Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M. Family and personal medical history and risk of meningioma. Journal Of Neurosurgery 2011, 115: 1072-7. PMID: 21780859, PMCID: PMC3241000, DOI: 10.3171/2011.6.jns11129.Peer-Reviewed Original ResearchConceptsFirst-degree family historyPersonal medical historyMedical historyFamily historyMeningioma riskEpidemiology of meningiomaPrimary brain tumorsCase-control studyRisk of meningiomaUterine fibroid tumorsImmune conditionsThyroid cancerYoungest caseBreast cancerRole of hormonesBrain tumorsFibroid tumorsImmune systemControl individualsPatientsMeningiomasInfluence of geneticsStrong associationFurther studiesTumors
2004
A Prospective Study of Perceived Susceptibility to Breast Cancer and Nonadherence to Mammography Screening Guidelines in African American and White Women Ages 40 to 79 Years
Calvocoressi L, Kasl SV, Lee CH, Stolar M, Claus EB, Jones BA. A Prospective Study of Perceived Susceptibility to Breast Cancer and Nonadherence to Mammography Screening Guidelines in African American and White Women Ages 40 to 79 Years. Cancer Epidemiology Biomarkers & Prevention 2004, 13: 2096-2105. PMID: 15598767, DOI: 10.1158/1055-9965.2096.13.12.Peer-Reviewed Original ResearchConceptsMammography screening guidelinesScreening guidelinesBreast cancerProspective studyFamily breast cancer historyWomen age 40Breast cancer historyScreening examinationCancer historyMammography screeningStudy populationAge 40Older womenUrban hospitalIndex examSubsequent adherenceTelephone interviewsPerceived susceptibilityWhite womenCancerMultiple covariatesWomenIndex screeningNonadherenceMonths